First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors
Clinical trial NCT06402201 · RECRUITING
Trial details
- NCT number
- NCT06402201
- Sponsor
- CDR-Life AG
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-24
- Primary completion
- 2026-06-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.